iD LifeStyle 3 Announcement

Hoya Introduces Innovative PAL Technology that Addresses Patient Focal and Adaptation Issues When Having a Different Prescription in Each Eye

LEWISVILLE, TEXAS, (November 29, 2018) Ophthalmic lens technology leader, HOYA Vision Care, announced today the U.S. launch of iD LifeStyle 3. The new lens design will offer three variations iD LifeStyle Indoor, iD LfeStyle Urban and iD LifeStyle Outdoor – each one easily fitted based on patient preferences.

“Lens designs evolve as we learn about how patients live with their lenses. In the data collected since the launch of iD LifeStyle 2 five years ago, there was a 70/30 split between the two available designs. That told us one group was too big and there is room for further refinement,” said Nick LaManna, Global Lens Product Manager for HOYA Vision Care, North America. He continued, “iD LifeStyle 3’s foundation is our patented Integrated Dual Surface Design technology and we added the Binocular Eye Model and Binocular Harmonization Technology. The combination of the three will provide a significant improvement in patient comfort and adaptation.”

There are three key things to know about the iD LifeStyle 3 design – First, it is built on Hoya’s patented Integrated Dual Side Optics platform. Integrated Dual Side Optics is the first and only method that truly separates the vertical and horizontal components of the prescription to provide patients with maximum comfort, customization and widest field of vision in all viewing zones.

Second, is HOYA’s implementation of patented Binocular Harmonization TechnologyTM (BHT) and the Binocular Eye ModelTM. How BHT works is the right and left prescription are treated as individual components to define the required binocular lens design and then the necessary corridor length and progressive power distribution are calculated. Patented algorithms and free form processing technology are implemented to achieve the finished product. The patient benefit is most pronounced for those with anisometropia, a difference in prescription between the right and left eye, which affects 73% of presbyopes*. The iD LifeStyle 3 lens design with BHT ensures that both eyes receive equal accommodative support, according to the needs of each eye to achieve optimal binocularity which will ensure easy adaptation.

And third is iD LifeStyle 3 has three easy to prescribe wearer profiles to choose from – Indoor, Urban and Outdoor. Indoor places emphasis on near vision focus, Urban wearers enjoy equal focus on all main vision areas, and Outdoor puts it primary focus on distance. A short conversation will quickly determine the design variation that is best suited for each patient. Options for varying the corridor are also available.

iD LifeStyle 3 is available to order. Your local Hoya Territory Sales Manager can provide you with more details.

*Source: Hoya data: European Progressive lens 2007-2013

About HOYA
Founded in 1941 in Tokyo, Japan, Hoya is a global technology and med-tech company, and a leading supplier of innovative high-tech and medical products. Hoya is active in the fields of healthcare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, Hoya currently employs a multinational workforce of 37,000 people. For more information, please visit http://www.hoya.com.

About HOYA Vision Care
For over 60 years, Hoya Vision Care has been a global leader in the eyeglass lens business. With a presence in over 50 countries, Hoya Vision Care has a proven expertise in lens designs and freeform surfacing technology combined with a leading position in high performance, quality AR coating. Hoya Vision Care’s solid market portfolio includes VISION EASE, SEIKO and PENTAX optical lenses, as well as innovative products such as Yuniku, the world’s first vision-centric, 3D tailored eyewear. The company employs over 16,000 employees worldwide with mass production facilities in Asia & Europe and over 40 local Rx laboratories globally. For more information, please visit www.hoyavision.com.

##